November 18, 2026
Health news, explained with evidence
LIVE
CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee

Debate Intensifies Over Universal Lipoprotein(a) Screening Guidelines

🧠 Mind & Mental Health 2 min read 👁 1

Medical experts are questioning the utility of universal lipoprotein(a) testing following a recent clinical trial failure and concerns over patient anxiety.

Debate Intensifies Over Universal Lipoprotein(a) Screening Guidelines🧠Mind & Mental Health

Photo: medpagetoday.com

Key points

  • New guidelines suggest universal Lp(a) testing for all adults.
  • Recent clinical trials for Lp(a)-lowering drugs have failed to show a reduction in heart disease events.
  • Critics argue that screening creates anxiety without offering specific, effective treatment options.

Recent guidelines from a coalition of 11 cardiology societies have sparked significant debate by recommending that all adults undergo at least one blood test for lipoprotein(a), or Lp(a). While proponents suggest that identifying elevated levels of this genetically inherited marker can help clinicians manage cardiovascular risk more aggressively, many physicians argue that the recommendation lacks clinical utility. Critics note that Lp(a) levels remain largely unaffected by lifestyle modifications like diet or exercise, and there is currently no proven treatment to reduce cardiovascular events by lowering these levels.

The controversy was further amplified by the failure of the HORIZON trial, which tested the drug pelacarsen. Although the medication successfully lowered Lp(a) levels, it did not lead to a reduction in major cardiovascular outcomes, such as heart attacks or strokes. This outcome has left many clinicians without a clear path forward for patients who test positive for high levels, raising concerns that the screening process may cause unnecessary distress without providing actionable medical benefits.

What to know: Some experts warn that universal screening may lead to a cascade of unnecessary diagnostic tests and increased patient anxiety. Because Lp(a) is a complex genetic marker, patients are encouraged to discuss the necessity of this test with their primary care physician, especially if they have other known cardiac risk factors. Always consult a medical professional before pursuing specialized cardiac screenings.

Source medpagetoday.com — medpagetoday.com/cardiology/generalcardiology/123952 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.